CoChat

Atenolol developmental toxicity: Animal‐to‐human comparisons

Tabacova, Sonia, Kimmel, Carole A., Wall, Kelly, Hansen, Deborah · 2003 · Birth Defects Research Part A: Clinical and Molecular Teratology
Cited by 44

The DOI matches its Crossref record.

Abstract

BACKGROUND: Atenolol, 4‐2′‐hydroxy‐3′‐isopropyl‐aminopropoxy) phenylacetamide, is a beta‐adrenoreceptor blocker used for treatment of hypertension in pregnancy. Beta‐blockers are reported to cause fetal harm (such as decreased birth weight) when administered to a pregnant woman. We evaluate published human and animal evidence of atenolol developmental toxicity and compare the manifestations in humans and in routinely‐used animal models. METHODS: The comparison is based on the following criteria: comparability of pharmacokinetic/pharmacodynamic characteristics, type of adverse outcome, lowest adverse effect levels, and specificity and selectivity of effect. RESULTS: Manifestations of atenolol prenatal toxicity (placental changes, intrauterine growth retardation and changes in fetal weight in the absence of structural malformations) are similar in the tested animal species (rats and rabbits) and humans. The human seems to be more sensitive, however, because adverse embryo‐fetal effects are reported at doses much lower than those in the tested species. In humans and rats, adverse embryo‐fetal effects are induced by doses that are not maternally toxic. In the rabbit, however, such effects are seen only at maternally toxic doses, suggesting that in this species, developmental toxicity may be maternally mediated. CONCLUSIONS: The available data suggest animal–human concordance with regard to the nature and manifestations of atenolol prenatal toxicity. The animal models “predicted” developmental toxicity manifests as placental changes, intrauterine growth retardation and fetal weight decrease in the absence of structural malformations. Thus far, this is concordant with the data from humans, in whom intrauterine growth retardation has been observed but not structural abnormalities. Birth Defects Research (Part A) 67:181–192, 2003. Published 2003 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/bdra.10011

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 44

Metadata

Authors
Tabacova, S., Kimmel, C. A., Wall, K., & Hansen, D.
Venue
Birth Defects Research Part A: Clinical and Molecular Teratology
Publisher
Wiley
Published
2003-03
Volume
67
Issue
3
Pages
181-192
ISSN
  • 1542-0752 (ISSN-L)
  • 1542-0760
OpenAlex
W1999262262
Cited by
44
References
0
FWCI
0.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Atenolol developmental toxicity: Animal‐to‐human comparisons. https://app.cochat.ai/papers/10.1002/bdra.10011
The paper
Tabacova, S., Kimmel, C. A., Wall, K., & Hansen, D. (2003). Atenolol developmental toxicity: Animal‐to‐human comparisons. Birth Defects Research Part A: Clinical and Molecular Teratology. https://doi.org/10.1002/bdra.10011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.